首页> 美国卫生研究院文献>Neuro-Oncology >P16.02ADC TEXTURE - AN IMAGING BIOMARKER FOR HIGH GRADE GLIOMA?
【2h】

P16.02ADC TEXTURE - AN IMAGING BIOMARKER FOR HIGH GRADE GLIOMA?

机译:P16.02ADC TEXTURE-高度胶质瘤的影像生物标记?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTION: Median survival for high grade gliomas is limited, at least partly explained by intratumoral heterogeneity contributing to treatment resistance. Radiological evaluation of treatment response is in most cases limited to assessment of tumor size months after the initiation of therapy. Diffusion weighted MRI and its estimate apparent diffusion coefficient, ADC, has been widely investigated, as it reflects tumor cellularity and proliferation. The aim of the present study was to investigate the potential of applying texture analysis in conjunction with multivariate ADC image for identifying early imaging biomarkers. MATERIALS AND METHODS: 23 consecutive high-grade glioma patients aged ≥18 years after diagnostic biopsy or resection were treated with radiotherapy (2 Gy/60 Gy) with concomitant and adjuvant temozolomide. MRI assessment three months after completion of radio-chemotherapy was used for classifying tumor progression or regression. A baseline exam was performed within one week before treatment start, day one, two weeks and six weeks into the treatment. ADC maps and T1 weighted anatomical images with and without contrast enhancement were collected, and (residual) tumor contrast enhancement was delineated. A gray-level co-occurrence matrix analysis was performed on the ADC maps in a cuboid encapsulating the tumor in coronal, sagittal and transversal planes, giving a total of 66 textural descriptors for each tumor. Principal component analysis, PCA, was applied to reduce dimensionality of the data, and the five largest components, or scores, were used in subsequent analyses. RESULTS: The score scatter plots revealed that the first, fourth and fifth components combined exhibited a pattern that strongly correlated to survival. Two groups could easily be identified: One with a median survival after diagnosis of 908 days and one with 299 days, p = 0.0005. MRI three months after completion of radiotherapy, age, surgical procedure and tumor grade all harbored prognostic information, but not to the same extent. CONCLUSION: By combining PCA and texture analysis ADC texture characteristics are identified, that seems to host pretreatment prognostic information, independent of known prognostic factors such as age, stage and surgical procedure. Validation of these data in a larger patient cohort is ongoing at our department.
机译:简介:高度神经胶质瘤的中位生存是有限的,至少部分是由于肿瘤内异质性导致了治疗耐药性。在大多数情况下,对治疗反应的放射学评估仅限于开始治疗后数月的肿瘤大小评估。扩散加权MRI及其估计的表观扩散系数ADC(ADC)已被广泛研究,因为它反映了肿瘤细胞的生长和增殖。本研究的目的是研究将纹理分析与多变量ADC图像结合用于识别早期成像生物标志物的潜力。材料与方法:连续23例诊断性活检或切除术后年龄≥18岁的高级别神经胶质瘤患者接受放疗(2 Gy / 60 Gy)并伴有替莫唑胺辅助治疗。放化疗结束后三个月的MRI评估用于分类肿瘤进展或消退。在治疗开始前一周,治疗的第一天,两周和六周内进行基线检查。收集具有和不具有对比增强的ADC图和T1加权的解剖图像,并描绘(残余)肿瘤对比增强。在将肿瘤包裹在冠状,矢状和横断面的长方体中,对ADC映射图进行了灰度共现矩阵分析,每个肿瘤共有66个纹理描述符。应用主成分分析PCA来减少数据的维数,并且在随后的分析中使用五个最大的成分或分数。结果:分数散点图显示,第一,第四和第五个成分的组合显示出与生存密切相关的模式。可以容易地识别出两组:诊断后中位生存时间为908天的一组和299天后的一组,p = 0.0005。放疗结束后三个月的MRI,年龄,手术方式和肿瘤分级均包含预后信息,但程度不同。结论:通过结合PCA和纹理分析,可以确定ADC的纹理特征,似乎具有治疗前的预后信息,而与已知的预后因素(例如年龄,分期和手术程序)无关。我们部门正在对更大的患者队列中的这些数据进行验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号